# Salient Aquamantys Spine Trial

> **NCT01331499** · PHASE4 · TERMINATED · sponsor: **Salient Surgical Technologies** · enrollment: 12 (actual)

## Conditions studied

- Blood Loss

## Interventions

- **DEVICE:** Bipolar Sealer (Aquamantys)
- **PROCEDURE:** Standard of Care

## Key facts

- **NCT ID:** NCT01331499
- **Lead sponsor:** Salient Surgical Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04
- **Primary completion:** 2012-12
- **Final completion:** 2013-04
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study terminated due to Medtronic acquisition
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331499, "Salient Aquamantys Spine Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01331499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*